Vaccines, blood, antisera, toxins and cultures in   Republic of the Congo

Exports In 2022, Republic of the Congo exported $4.22k in Vaccines, blood, antisera, toxins and cultures, making it the 173rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 320th most exported product in Republic of the Congo. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Republic of the Congo are: France ($1.66k), Sao Tome and Principe ($1.31k), Philippines ($1.16k), South Korea ($99), and Canada ($1).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Republic of the Congo between 2021 and 2022 were Sao Tome and Principe ($1.31k), Philippines ($1.16k), and South Korea ($99).

Imports In 2022, Republic of the Congo imported $144M in Vaccines, blood, antisera, toxins and cultures, becoming the 89th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most imported product in Republic of the Congo. Republic of the Congo imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($128M), United States ($11.6M), India ($2.22M), China ($942k), and South Korea ($722k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Republic of the Congo between 2021 and 2022 were Belgium ($103M), United States ($7.46M), and India ($1.73M).